HBK Sorce Advisory LLC Acquires New Stake in Senseonics Holdings, Inc. $SENS

HBK Sorce Advisory LLC bought a new position in shares of Senseonics Holdings, Inc. (NYSE:SENS) during the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor bought 83,398 shares of the company’s stock, valued at approximately $39,000.

Several other institutional investors also recently bought and sold shares of the company. First Light Asset Management LLC lifted its position in shares of Senseonics by 666.7% during the second quarter. First Light Asset Management LLC now owns 35,708,124 shares of the company’s stock worth $17,011,000 after purchasing an additional 31,050,619 shares in the last quarter. Geode Capital Management LLC grew its holdings in shares of Senseonics by 26.6% in the second quarter. Geode Capital Management LLC now owns 8,701,129 shares of the company’s stock valued at $4,147,000 after purchasing an additional 1,828,302 shares in the last quarter. Hood River Capital Management LLC purchased a new stake in Senseonics during the 2nd quarter worth approximately $3,775,000. Sio Capital Management LLC acquired a new stake in Senseonics during the 2nd quarter worth approximately $2,312,000. Finally, Charles Schwab Investment Management Inc. lifted its holdings in Senseonics by 4.9% during the 1st quarter. Charles Schwab Investment Management Inc. now owns 3,502,326 shares of the company’s stock worth $2,298,000 after buying an additional 162,628 shares in the last quarter. 12.36% of the stock is owned by institutional investors and hedge funds.

Insiders Place Their Bets

In other Senseonics news, CFO Frederick T. Sullivan acquired 5,415 shares of the stock in a transaction dated Friday, November 7th. The stock was acquired at an average cost of $5.88 per share, with a total value of $31,840.20. Following the transaction, the chief financial officer owned 157,028 shares in the company, valued at $923,324.64. The trade was a 3.57% increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Douglas A. Roeder bought 15,000 shares of the business’s stock in a transaction dated Friday, November 7th. The shares were acquired at an average cost of $5.83 per share, for a total transaction of $87,450.00. Following the transaction, the director directly owned 99,727 shares in the company, valued at approximately $581,408.41. This represents a 17.70% increase in their position. Additional details regarding this purchase are available in the official SEC disclosure. Insiders acquired 30,415 shares of company stock valued at $184,790 in the last ninety days. Insiders own 3.60% of the company’s stock.

Senseonics Price Performance

Senseonics stock opened at $6.02 on Friday. The company has a current ratio of 2.47, a quick ratio of 2.38 and a debt-to-equity ratio of 59.17. The company has a fifty day simple moving average of $6.49 and a 200-day simple moving average of $8.52. The stock has a market cap of $245.97 million, a P/E ratio of -46.31 and a beta of 0.92. Senseonics Holdings, Inc. has a 12-month low of $5.25 and a 12-month high of $28.00.

Analyst Ratings Changes

A number of analysts have recently weighed in on the company. TD Cowen cut their price objective on Senseonics from $25.00 to $15.00 and set a “buy” rating on the stock in a research report on Wednesday, November 5th. Stifel Nicolaus assumed coverage on Senseonics in a report on Tuesday, October 21st. They issued a “hold” rating and a $9.00 target price for the company. HC Wainwright upped their price target on Senseonics to $18.50 and gave the stock a “buy” rating in a report on Thursday, November 6th. Finally, Barclays reaffirmed an “overweight” rating and issued a $31.00 price target (up previously from $1.50) on shares of Senseonics in a research report on Wednesday, November 5th. Two analysts have rated the stock with a Strong Buy rating, three have given a Buy rating and one has given a Hold rating to the company. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Buy” and an average price target of $22.70.

Senseonics Profile

Senseonics Holdings, Inc is a medical technology company focused on the development and commercialization of innovative continuous glucose monitoring (CGM) systems for people with diabetes. Since its founding in 2011 and headquartered in Germantown, Maryland, the company has pioneered an implantable sensor designed to deliver long-term glucose readings. Senseonics’ mission centers on improving diabetes management by providing accurate, real-time data to patients and healthcare providers.

The company’s flagship offering is the Eversense CGM System, which features a small, fully implantable sensor placed beneath the skin to measure glucose levels for up to 90 days in the United States and up to 180 days in Europe.